Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study
Vaccines · 15.04.2023 · 11 (4) · 850
DOI: 10.3390/vaccines11040850 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Vaccines, online erschienen am 15.04.2023. Verfasst von Alina Cernasev und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, U…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Merck Fund, Merck Sharp & Dohme Corp.
Abstract (Originalsprache)
Background
In the last several decades, vaccine hesitancy has become a significant global public health concern. The human papillomavirus (HPV) vaccine has been on the United States of America (USA) market since 2006, with extended approval up to age 45 granted in 2018. To date, there is limited research evaluating barriers and facilitators related to HPV vaccine initiation among adults and the influence of the COVID-19 pandemic on individuals’ vaccine-related behaviors. This study’s main objective was to characterize the contributing factors that could promote or inhibit HPV vaccine uptake for adults.
Methods
A qualitative approach consisting of focus group discussions (FGDs) was used for this study. The FGD guide was informed by concepts from the Transtheoretical Model, Health Belief Model, and Social Cognitive Theory. All virtual FGDs were led by two researchers, who recorded audio for data collection. The data were transcribed by a third party, and the transcripts were imported into Dedoose® software and analyzed using the six steps recommended by thematic analysis.
Results
A total of 35 individuals participated in 6 focus groups over a 6-month period. Thematic analysis revealed four themes: (1) Intrinsic motivators for HPV vaccination, (2) Extrinsic motivators for HPV vaccination, (3) Vaccine promotion strategies, and (4) Impact of COVID-19 Pandemic on vaccine hesitancy.
Conclusion
Both intrinsic and extrinsic factors play a role in influencing HPV vaccine uptake, and such considerations can guide efforts to improve the odds of HPV vaccination in working-age adults.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, USA.
- Department of Public Health, University of Tennessee Knoxville, Knoxville, TN 37996, USA.
- Department of Environmental, Agricultural & Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- US Health Outcomes Vaccines, GSK, Philadelphia, PA 19104, USA.
ORCID-Profile: Kenneth C Hohmeier, Kristina W Kintziger
Förderung
- John Merck Fund
- Merck Sharp & Dohme Corp
Zitieren
APA
Cernasev, A., Hohmeier, K. C., Oyedeji, O., Hagemann, T., Kintziger, K. W., Wisdom, T., & Gatwood, J. (2023). Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study. Vaccines, 11(4), 850. https://doi.org/10.3390/vaccines11040850
Vancouver
Cernasev A, Hohmeier KC, Oyedeji O, Hagemann T, Kintziger KW, Wisdom T, et al. Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study. Vaccines. 2023;11(4):850. doi:10.3390/vaccines11040850
BibTeX
@article{Cernasev2023,
author = {Cernasev, Alina and Hohmeier, Kenneth C and Oyedeji, Oluwafemifola and Hagemann, Tracy and Kintziger, Kristina W and Wisdom, Taylor and Gatwood, Justin},
title = {Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {4},
pages = {850},
doi = {10.3390/vaccines11040850}
}
EUVIMED